CCL5 and myeloid sarcoma: Moreover, IL-1ra (interleukin-1 receptor antagonist), PDGF-bb (platelet-derived growth factor BB), and RANTES (regulated upon activation, normal T-cell expressed and presumably secreted) increased in SZ patients but decreased in MS patients as compared to corresponding controls.